Cancer Treatment Cost in Chennai : Affordability and Accessibility for International patients

Cancer is one of the deadliest diseases, and its treatment can be extremely costly. In Chennai, the cost of cancer treatment starting from 1000 USD for International patients is relatively affordable compared to other countries, which makes it an attractive destination for medical tourism. In this article, we will discuss the affordability and accessibility of cancer treatment in Chennai, including the cost of chemotherapy and immunotherapy, cervical cancer vaccine, pembrolizumab cost, and the availability of best cancer hospitals in Chennai.

Best Cancer Hospitals in Chennai

Chennai has several top-notch cancer hospitals with state-of-the-art facilities and world-class infrastructure. Some of the best cancer hospitals in Chennai are:

Apollo Cancer Hospital - Apollo Cancer Centre in India first ISO certified healthcare provider. Hospital Ranked among the best super specialty hospitals , offering advanced tertiary care in Oncology, Orthopedics, Neurology and Neurosurgery, Head and Neck surgery and Reconstructive and Plastic surgery. Equipped with 300+ beds, the latest and the best technology, manned by a large pool of world renowned specialists and supported by a dedicated team of medical and paramedical professionals....read more 

Apollo Proton Cancer Centre - APCC has a fully integrated treatment suite that offers the most advanced cancer treatment in surgical, radiation and medical procedures. Apollo Hospital Pillars of Expertise and Excellence, the Centre brings together a powerful team of clinicians renowned globally in cancer care. APCC's approach treating cancer is its robust multi-disciplinary platform; highly skilled clinicians who come together to form a cancer management team(CMT)....read more

Apollo Hospital, Greams Road - First hospital in South India to be accredited by the Joint Commission International USA and subsequently reaccredited 4 times. Declared as the 'Centre of Excellence' by the Government of India. Voted several times as the "Best Private Sector Hospital in India" by The Week magazine. Bagged the top 2 positions in the All India Multispecialty Hospital Survey 2016 conducted by Times Health. NABH and JCI Accredited....read more

SIMS Hospital - SIMS Hospital-Vadapalani in Chennai is one of the fastest growing multi-super speciality tertiary care hospitals in India, spread over 2,30,000 sq ft. Patient-centric facilities at SIMS Hospital-Vadapalani, Chennai will ensure to deliver the exceptional quality of patient care. This facilities are designed and equipped to meet the discerning requirements of both domestic and international patients. Hospital Patient rooms are designed with all modern comforts. Patients and family members experience a serene environment that offers them privacy and space, giving them a new experience in the health care industry....read more

MIOT International Hospital - 1000+ bed facility offering superlative treatment in 63 specialities. MIOT hospital proudly lays claim to a team of world-class professionals who use our state-of-the-art infrastructure and cutting-edge technology to heal and give hope patients. Hospital Consistently adjudged as a leader in healthcare, MIOT International attracts patients from 130 countries who seek our expertise in moving towards wellness....read more

Chemotherapy and immunotherapy are the two most common cancer treatment options available. Chemotherapy involves the use of drugs to kill cancer cells, while immunotherapy stimulates the immune system to fight cancer. The cost of chemotherapy and immunotherapy in India is significantly lower compared to other countries.

Cervical Cancer Vaccine Cost:

Cervical cancer is the second most common cancer in women in India. The HPV vaccine is recommended for girls aged 9-14 years to prevent cervical cancer. The cost of the HPV vaccine in India ranges from INR 3,000 to INR 10,000 per dose, and two to three doses are required.

Pembrolizumab Cost:

Pembrolizumab is an immunotherapy drug used to treat various types of cancer, including melanoma, lung cancer, and head and neck cancer. The cost of pembrolizumab in India is significantly lower than in other countries. In India, the cost of pembrolizumab can range from INR 50,000 to INR 1.5 lakhs per cycle.

WDI Medical Tourism and Research Pvt Ltd. is a medical tourism company based in India that provides affordable and accessible healthcare solutions to patients from around the world. The company offers a wide range of services, including cancer treatment, organ transplants, and orthopaedic surgery.

WDI Medical Tourism and Research Pvt Ltd. have tie-ups with some of the best cancer hospitals in Chennai, including Apollo Hospital, Apollo Proton Center, SIMS Hospital. The company offers end-to-end services, including visa assistance, travel arrangements, accommodation, and post-treatment follow-up.

Conclusion:

In conclusion, India is an affordable and accessible destination for cancer treatment, and it attracts patients from around the world. The cost of chemotherapy and immunotherapy in India is significantly lower compared to other countries, and there are several top cancer hospitals with world-class facilities. The cost of the cervical cancer vaccine and pembrolizumab is also relatively lower in India. Health insurance policies specifically for cancer patients are also available in India.

Moreover, WDI Medical Tourism and Research Pvt Ltd. offer a range of services that can help international patients access the best cancer treatment in India. With tie-ups with some of the best cancer hospitals in India, the company offers end-to-end services to patients, including visa assistance, travel arrangements, and post-treatment follow-up.

In conclusion, cancer treatment in India is affordable and accessible. With the help of companies like WDI Medical Tourism and Research Pvt Ltd., international patients can access the best healthcare services in India. However, it is crucial to consult with a medical professional and do thorough research before making any healthcare-related decisions.